Corporate information

Official name
Roche Holding AG
Affiliated entities

Funding rounds

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
InterMune Inc Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. Acquisition Initial investment led the round USD 8,300,000,000 (USD 8,300,000,000)

Current team

Past employees

Selected Products / Customers

Selected Suppliers

Financials